HIV 1 News and Research

RSS

Cryo-EM experiments offer important clues to chicken pox infection

Despite decades of study, exactly how herpesviruses invade our cells remains something of a mystery. Now researchers studying one herpesvirus, the varicella zoster virus (VZV) that causes chicken pox, may have found an important clue: A key protein the virus uses to initiate infection does not operate as previously thought, researchers at Stanford University and the Department of Energy's SLAC National Accelerator Laboratory report August 18 in Nature Communications.

18 Aug 2020

Non-sustained research on emerging infectious diseases endangers pandemic responses

Lack of Continuing Research Into Infectious Disease Epidemics Endangers Pandemic Responses, According to Ben-Gurion University Researchers

18 Aug 2020

Wits University begins South African trial of Novavax COVID-19 vaccine

NVX-CoV2373 is produced by the biotech company, Novavax (Maryland, U.S.A). Novavax is a late-stage biotechnology company that develops next-generation vaccines for serious infectious diseases.

17 Aug 2020

Startling report suggests COVID-19 may have first appeared in 2012

Now, a report on the website Independent Science News by researchers Jonathan Latham, and Allison Wilson suggests that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes the coronavirus disease (COVID-19), may not have originated at a Wuhan wet market in 2019, but 1,000 miles away in 2012, in a Chinese mineshaft where workers fell ill with a mysterious, pneumonia-like illness after being exposed to bats.

17 Aug 2020

Coronacept - A trap-and-destroy molecule against SARS-CoV-2

A new study published on the preprint server bioRxiv* in August 2020 reports a novel engineered molecule based on human and other mammalian orthologues of ACE2 fused with the Fc part of the antibody. This molecule interacts more tightly with the viral receptor-binding domain (RBD) to constitute a powerful immunoadhesin that targets the virus for destruction.

17 Aug 2020

Online platform for STI testing receives more than 5000 home kit order requests

As the Covid-19 pandemic resulted in changes to the provision of NHS services, an online platform offering home tests was introduced throughout Wales - enabling service users to access STI testing at home.

13 Aug 2020

Diversions in malaria prevention efforts during the pandemic may cost thousands of lives

As COVID-19 threatens to derail more than a decade’s worth of hard-won gains in the fight against malaria, Dr Benjamin Pretorius, managing director at ERADA Technology Alliance, warns that diversions of malaria resources and interruptions to prevention programmes may cost thousands of lives.

13 Aug 2020

Australian researcher receives Campbell Foundation's grant to study HIV prevention methods

The Campbell Foundation, a Fort Lauderdale-based nonprofit that provides grants to support alternative clinical approaches to the treatment and prevention of HIV/AIDS, has awarded an $85,000 grant to Gilda Tachedjian, PhD., Head of Life Sciences and Principal Investigator at Burnet Institute in Melbourne, Australia.

13 Aug 2020

New treatment regimens show early efficacy for multidrug-resistant tuberculosis

New treatment regimens for multidrug-resistant tuberculosis (MDR-TB) have shown early effectiveness in 85 percent of patients in a cohort that included many people with serious comorbidities that would have excluded them from clinical trials, according to the results of a new international study.

13 Aug 2020

Researchers explore association of malaria, HIV with anemia during pregnancy

Pregnant women from sub-Saharan Africa with malaria and human immunodeficiency virus (HIV) have a higher prevalence of anemia than pregnant women without infections according to Penn State College of Medicine researchers.

12 Aug 2020

Mount Sinai's Arnhold Institute for Global Health and NYC Health + Hospitals launch CURE-19

The Arnhold Institute for Global Health at the Icahn School of Medicine at Mount Sinai and NYC Health + Hospitals have launched the COVID-19 Unit for Research at Elmhurst (CURE-19).

12 Aug 2020

Short-term PrEP use could be a successful way to prevent HIV spread in at-risk men on vacation

Men at particular risk for HIV are very likely to consistently take prevention medication during vacations when their odds of contracting the virus are higher, according to a new study led by scientists at the University of Pittsburgh Graduate School of Public Health, The Fenway Institute and Harvard University.

12 Aug 2020

C-type lectin receptors play a role in SARS-CoV-2 infection

A new study published on the preprint server bioRxiv in August 2020 confirms and extends earlier findings showing that a type of sugar-based receptor on innate immune cells promotes the entry of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) into other cells that carry the viral receptor, angiotensin-converting enzyme 2 (ACE2).

12 Aug 2020

Study identifies three potential drugs to eradicate parasitic worms

Scientists have revealed a way to eradicate parasitic worms by stopping them from using alternative metabolism pathways provided by bacteria that live within them, according to new findings published today in eLife.

12 Aug 2020

Protein uses two different mechanisms to inhibit viral infections

To protect humans against infection, a protein called MARCH8 tags the vesicular stomatitis virus (VSV) for destruction while it merely holds HIV hostage, a new study in eLife shows.

11 Aug 2020

Specific HIV and tuberculosis medications decrease risk of death in adults with drug-resistant TB

After looking at the health records of over 10,000 patients with both HIV and multidrug resistant Tuberculosis (TB) in over 20 different countries, researchers at the Perelman School of Medicine at the University of Pennsylvania in collaboration with the Centers for Disease Control and Prevention, McGill University, and other institutions around the world, found that implementing antiretroviral therapy (ART) for HIV and newer tuberculosis medications decreased the risk of death for adults with drug-resistant TB.

11 Aug 2020

COVID-19 Prevention Network announces Phase 3 trials to evaluate monoclonal antibodies

The COVID-19 Prevention Network (CoVPN) today announced two Phase 3 trials to determine whether monoclonal antibodies (mAbs) can prevent SARS-CoV-2, the virus that causes COVID-19.

11 Aug 2020

NIH supports research on how pathogens evolve

For several years, physicist John Barton at the University of California, Riverside, has been working on developing models to understand and predict how pathogens, such as HIV, evolve. This research pursuit has just received support from the National Institutes of Health.

10 Aug 2020

Baylor Scott & White Research Institute enrolls first patients in NIH ACTIV-3 clinical trial

On Wednesday, August 5, in Dallas, just one day after the initiative was launched by the National Institutes of Health, Baylor Scott & White Research Institute enrolled the first patient in the world for the ACTIV-3 clinical trial. A second patient was enrolled the following day.

10 Aug 2020

New articles focus on recent developments in the field of health preference research

Value in Health, the official journal of ISPOR - the professional society for health economics and outcomes research, announced today the publication of a series of articles focused on recent developments in the field of health preference research.

10 Aug 2020

HIV 1 News and Research

Cryo-EM experiments offer important clues to chicken pox infection

Non-sustained research on emerging infectious diseases endangers pandemic responses

Wits University begins South African trial of Novavax COVID-19 vaccine

Startling report suggests COVID-19 may have first appeared in 2012

Coronacept - A trap-and-destroy molecule against SARS-CoV-2

Online platform for STI testing receives more than 5000 home kit order requests

Diversions in malaria prevention efforts during the pandemic may cost thousands of lives

Australian researcher receives Campbell Foundation's grant to study HIV prevention methods

New treatment regimens show early efficacy for multidrug-resistant tuberculosis

Researchers explore association of malaria, HIV with anemia during pregnancy

Mount Sinai's Arnhold Institute for Global Health and NYC Health + Hospitals launch CURE-19

Short-term PrEP use could be a successful way to prevent HIV spread in at-risk men on vacation

C-type lectin receptors play a role in SARS-CoV-2 infection

Study identifies three potential drugs to eradicate parasitic worms

Protein uses two different mechanisms to inhibit viral infections

Specific HIV and tuberculosis medications decrease risk of death in adults with drug-resistant TB

COVID-19 Prevention Network announces Phase 3 trials to evaluate monoclonal antibodies

NIH supports research on how pathogens evolve

Baylor Scott & White Research Institute enrolls first patients in NIH ACTIV-3 clinical trial

New articles focus on recent developments in the field of health preference research

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News